St. Jude Medical (STJ) pacemaker worked properly - Bloomberg, citing Univ. of Mich. researchers
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
St. Jude Medical (NYSE: STJ) pacemaker worked properly, according to Bloomberg, citing University of Michigan researchers.
The researchers said Muddy Waters' study was flawed.
The study was conducted independently, according to headlines.
St. Jude shares are popping to session highs amid the news.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharma (ACAD) on Watch Following Cautious Mention
- Equity and Commodity Markets Movements
- Stocks with Implied Volatility Movement)